Figure 1.
TFHdevelopment in healthy children and adults and in patients post-HSCT. Percentage of TFH (the percentage of CD4+ T cells that are CD45RA− and CXCR5+) was measured in (A) umbilical cord blood (UCB), healthy children of the ages shown, and healthy adults; (B) patients with IL2RG/JAK3 SCID at varying times post-HSCT; and patients with IL2RG/JAK3 SCID analyzed according to (C) conditioning, (D) donor B-cell chimerism, (E) Ig replacement status, and (F) response to tetanus vaccine. Medians and interquartile ranges are shown.

TFHdevelopment in healthy children and adults and in patients post-HSCT. Percentage of TFH (the percentage of CD4+ T cells that are CD45RA− and CXCR5+) was measured in (A) umbilical cord blood (UCB), healthy children of the ages shown, and healthy adults; (B) patients with IL2RG/JAK3 SCID at varying times post-HSCT; and patients with IL2RG/JAK3 SCID analyzed according to (C) conditioning, (D) donor B-cell chimerism, (E) Ig replacement status, and (F) response to tetanus vaccine. Medians and interquartile ranges are shown.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal